Avonex (interferon beta-1a) for multiple sclerosis
The FDA will soon approve Avonex (interferon beta-1a) for multiple sclerosis.
It's a beta-interferon...similar to Betaseron.
Both Avonex and Betaseron help reduce the frequency of relapses in patients with the relapsing-remitting form of MS. In addition, Avonex also slows the progression of the disease.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote